Follow
Next-Generation Sequencing
Next-Generation Sequencing: A high-throughput method used to determine a portion of the nucleotide sequence of an individual's genome. This technique utilizes DNA sequencing technologies that are capable of processing multiple DNA sequences in parallel. Also called massively parallel sequencing and NGS.
MAR 17, 2025 | 8:00 AM
This session provides an introduction to the MiSeq i100 Series, the simplest, fastest benchtop sequencer. Giving a brief overview of the revolutionary technology that's been built into the n...
FEB 04, 2025 | 10:00 AM
When the Precision Medicine Initiative was launched in 2015, it completely transformed patient care in oncology. Now, individual differences in genetics, environment and lifestyle, along wit...
JAN 29, 2025 | 8:15 AM
C.E. CREDITS
Webinar 2 will focus on specimen types, specimen management, extraction, quantification, and various types of library preparation (amplicon vs. hybrid capture) for DNA. We will also include...
NOV 19, 2024 | 8:00 AM
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairsâ„¢ (SCIP). Gene editing is used to introduce single nucle...
OCT 31, 2024 | 8:00 AM
Liquid biopsy next-generation sequencing (NGS) assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable or during disease progression. Extensiv...
OCT 17, 2024 | 8:15 AM
C.E. CREDITS
In this first webinar, we will cover various applications for NGS and different aspects of comprehensive genomic tests, including variants, C...
OCT 02, 2024 | 12:00 PM
Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer...
SEP 19, 2024 | 10:00 AM
In the rapidly evolving field of oncology, precision medicine stands at the forefront of providing personalized patient care. Our upcoming webinar, "Transforming Oncology Diagnostics: I...
JUN 27, 2024 | 10:00 AM
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in...
JUN 26, 2024 | 8:00 AM
This webinar explores the groundbreaking impact of innovative NGS enzymes on reshaping the landscape of next-generation sequencing (NGS) and accelerating NGS democratization in diagnostics....
JUN 21, 2024 | 12:00 AM
Rapid detection and identification of microbial pathogens in the laboratory is imperative. However, standard microbiology testing approaches often depend on the recovery and culture of viabl...
JUN 19, 2024 | 12:00 PM
Measurable or minimal residual disease (MRD) is the presence of very small numbers of tumor cells which may remain in the body following treatment. MRD testing currently has multiple clinica...
MAY 22, 2024 | 9:00 AM
C.E. CREDITS
Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-191. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for...
MAY 15, 2024 | 10:30 AM
Next-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. But as NGS is increasin...
MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...
MAR 20, 2024 | 8:00 AM
Deciphering somatic mosaicism in healthy tissues and clonal diversity in tumors necessitates single-cell analysis. High-quality genomic and transcriptomic data at the single-cell level depen...
FEB 28, 2024 | 10:00 AM
Mariana Kiehl (Sr. Applications Scientist at Roche Sequencing & Life Science) describes the KAPA Total Prep FFPE workflow, a novel single-tube method for combined sequencing of DNA and R...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 30, 2023 | 8:00 PM
Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
OCT 02, 2024 | 12:00 PM
Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer...